Venus Remedies achieves major milestone with UNICEF

Venus Remedies has proudly reached a significant milestone by securing the prestigious award for its antibiotic product, Ceftriaxone 1gm, from UNICEF in the Beta Lactam tender. This recognition follows the earlier achievement of receiving GMP (Good Manufacturing Practices) approval from UNICEF, which underscores our commitment to maintaining exceptional quality standards.

UNICEF's decision to award the tender to Venus Remedies Limited is a testament to our relentless pursuit of excellence in healthcare. Our Ceftriaxone 1gm product has met and surpassed stringent quality criteria, demonstrating our dedication to producing top-tier pharmaceutical solutions. This award not only highlights our product's superior quality but also reinforces our role as a trusted partner in global health initiatives.

Venus Remedies Limited will continue to uphold the highest standards of quality and commitment, ensuring that our products contribute significantly to the well-being of communities around the globe and remain dedicated to our mission of advancing global health through innovation and excellence in the pharmaceutical industry.

Shares of Venus Remedies Limited was last trading in BSE at Rs. 355.15 as compared to the previous close of Rs. 323.05. The total number of shares traded during the day was 35695 in over 2201 trades.

The stock hit an intraday high of Rs. 362.00 and intraday low of 323.10. The net turnover during the day was Rs. 12500286.00.

Source : Equity Bulls

Keywords

VenusRemedies INE411B01019 OrderWin Antibiotic Ceftriaxone 1gm UNICEF BetaLactamTender